Parkinson's disease

Parkinson’s Disease Abstract Parkinson’s Disease is a very common disorder these days. Over 10 million people live daily with Parkinson worldwide. Parkinson’s Disease was named after an English surgeon James Parkinson who wrote a detailed description essay called Shaking Palsy in 1817. The average age for Parkinson’s Disease is between 45 to 70 years old but you can also have juvenile or young onset as well. Most common symptoms of Parkinson are tremors, bradykinesia or akinesia, or rigidity or

Many people around the world today suffer from Parkinson’s disease and other movement disorders. A movement disorder is a disorder impairing the speed, fluency, quality, and ease of movement. There are many types of movement disorders such as impaired fluency and speed of movement (dyskinesia), excessive movements (hyperkinesia), and slurred movements (hypokinesia). Some types of movement disorders are ataxia, a lack of coordination, Huntington's disease, multiple system atrophies, myoclonus, brief

Mathur states that “Genetics loads the gun, environment pulls the trigger” (Mathur). Parkinson’s Disease (PD) exhibits this pattern, with the vast majority of PD cases being idiopathic, likely the result of combined genetic and environmental factors. While many researchers previously sought symptom-specific treatment, recent breakthroughs open the door for the discovery of genetic and environmental causes so that disease prevention, and even reversal, emerge as viable possibilities. Recent research demonstrates

The Overshadowed Disease When people hear the words Parkinson’s disease they think, “Isn’t that what Michael J. Fox has?” For those who are asking, “Who is Michael J. Fox?” He was the character Marty McFly in the “Back to the Future” movie and played on many TV shows. After being diagnosed with Parkinson’s disease, he set up an organization to research Parkinsonism. What the Michael J. Fox Foundation found was that 40 percent of the people living with Parkinson’s disease experience dystonia as

In the United States there is an estimated 1 million people living with Parkinson’s disease, with the worldwide numbers reaching an estimated 10 million people (American Parkinson’s Disease Association, 2017). Parkinson’s disease, commonly referred to as Parkinson’s, is a neurodegenerative disorder that slowly and progressively deteriorates the central nervous system (Falvo, 2014). This progressive deterioration occurs mostly in the basal ganglia, a structure in the brain composed of grey matter

with Parkinson’s disease. Of the 15 articles occupational therapy and drug therapy were used to decrease the symptoms of Parkinson’s disease. Some of the articles had found similar findings, but varied in different aspects. The two tables in this section discuss the main findings of research done on Parkinson’s Disease in regards to the effectiveness of different treatment options. Specifically, occupational therapy and drug therapy. Table 1 discusses the studies related to elderly Parkinson’s patients

Parkinson’s disease (PD) is a striatal dopamine deficiency disorder as a consequence of neuronal loss in the substania nigra. It is named after James Parkinson, a British apothecary, who first fully documented its physical signs in 1817. Since then, significant advances have been made in our understanding of characteristic pathophysiology as well as in the medical treatment of different stages of PD. An overview of condition features in terms of epidemiology, manifestations, diagnosis and disease

* Parkinson: Parkinson’s disease affects dopamine producing cells of the brain; the symptoms include muscle rigidity, tremors, and changes in speech and gait. Parkinson's

Parkinson’s disease (PD) is a motor system disorder that affects the brain’s dopaminergic system, which transmits the neurotransmitter dopamine through dopaminergic pathways. The substantia nigra is a darkly pigmented structure that projects one of the body’s three distinct dopaminergic pathways. The substantia nigra links to the globus pallidus of the basal ganglia, which consists of several subcortical structures (including the substantia nigra). The basal ganglia are connected to the motor regions

Parkinson’s disease is a chronic brain disorder that limits mobility in patients that are diagnosed with it. Information about the disease was first published in Western medicine in 175 AD, although evidence of it it has been seen since earlier ancient times. Since then, much has been learned about the disease. In the 1960s, the differences in chemicals in the brains of Parkinson’s disease patients were first identified. Researchers now believe that Parkinson’s is caused by the gradual breakdown